课题基金 / 基金详情

IGF::OT::IGF VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): A STUDY TO IDENTIFY MOLECULES (SIMILAR TO RR505) THAT TARGETS DUAL SPECIFIC PHOSPHATASE5 (DUSP5)

IGF::OT::IGF VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): A STUDY TO IDENTIFY MOLECULES (SIMILAR TO RR505) THAT TARGETS DUAL SPECIFIC PHOSPHATASE5 (DUSP5)
IGF::OT::IGF 血管干预/创新和治疗进展 (VITA)：一项识别针对双特异性磷酸酶 5 (DUSP5) 的分子（类似于 RR505）的研究
批准号：
9201098
负责人：
APRIL HAVERTY
金额：
$21.17万
依托单位：
MEDICAL COLLEGE OF WISCONSIN
依托单位国家：
美国
项目类别：
财政年份：
2013
资助国家：
美国
项目状态：
已结题
起止时间：
2013-11-15 至 2016-11-14
来源：
https://reporter.nih.gov/project-details/9201098
关键词：
AblationBlood VesselsContractsDefectDevelopmentDiagnosticDiseaseExcisionFamilyGoalsInterventionLeadLocationMedicalModalityNational Heart, Lung, and Blood InstitutePatientsProceduresPulmonary HypertensionStagingSupport ContractsTechniquesTherapeuticTherapeutic InterventionVascular Diseasesdrug candidateexperienceinnovationmalformationmedical complicationproduct developmentprograms

项目摘要

项目成果

APRIL HAVERTY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Vascular Interventions/Innovations and Therapeutic Advances (VITA) Program is a new translational initiative of the National Heart, Lung, and Blood Institute (NHLBI) that enables and accelerates the development of promising diagnostic and therapeutic modalities for unmet and underserved medical needs. The VITA Program provides contract support for early-stage translational development of product candidates in the fields of vascular disorders, thrombotic diseases, and pulmonary hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金